CELZ is Creative Medical Technology Holdings, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.06. Market cap: $7M. Capital Quality Rank: 6/100 — Systemic risk.
Stock snapshot
| Price | $1.06 |
| Market cap | $7M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 6 / 100 · Systemic risk |
| ROIC (TTM) | -969.2% |
| Revenue CAGR (3y) | -59.2% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About CELZ
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Related non-dividend companies
Other non-dividend stocks investors research alongside CELZ. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CELZ's current stock price?
CELZ (Creative Medical Technology Holdings, Inc.) is currently trading at $1.06.
Does CELZ pay a dividend?
CELZ (Creative Medical Technology Holdings, Inc.) does not currently pay a regular dividend.
What is CELZ's Capital Quality Rank?
CELZ has a Capital Quality Rank of 6/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CELZ in DiviDrip
Add CELZ to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CELZ and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.